Jens Rokkedal

Glostrup Hospital — Denmark

Medicine · Health Sciences

20h-index2.2kcitations37works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiovascular Function and Risk Factors(22), Blood Pressure and Hypertension Studies(17), Cardiovascular Health and Disease Prevention(10), Cardiac Imaging and Diagnostics(7), Heart Failure Treatment and Management(5)

Publications37 total

Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study)
The American Journal of Cardiology·2010· 50 cited
In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study
Journal of Hypertension·2010· 47 cited
In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study
Blood Pressure·2010· 65 cited
Does long‐term losartan‐ vs atenolol‐based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy
Blood Pressure·2006· 9 citedOpen Access
Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy
Blood Pressure·2005· 52 cited
Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy
Journal of Hypertension·2005· 38 cited
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation
Journal of the American College of Cardiology·2005· 245 cited
Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy
Journal of Human Hypertension·2005· 38 cited
Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy)
The American Journal of Cardiology·2004· 30 cited
Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study
American Heart Journal·2004· 23 cited
Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol
Circulation·2004· 466 cited
N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy
Journal of Hypertension·2004· 91 cited
24-h Ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: left ventricular geometry and urinary albumin excretion—a LIFE substudy
Journal of Human Hypertension·2004· 18 cited
Is inappropriate left ventricular mass related to neurohormonal factors and/or arterial changes in hypertension? a LIFE substudy
Journal of Human Hypertension·2004· 8 citedOpen Access
Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy
Journal of Human Hypertension·2004· 40 cited
888-1 N-terminal pro brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: A LIFE study
Journal of the American College of Cardiology·2004· 9 cited
Are NT-Pro brain natriuretic peptides related to systolic and diastolic left ventricular function at baseline and during antihypertensive treatment? The LIFE study
Journal of the American College of Cardiology·2003· 1 cited
The effect of losartan versus atenolol on aortic valve sclerosis: A LIFE study
Journal of the American College of Cardiology·2003· 3 cited
Cardiovascular morbidity and mortality in hypertensive patients with atrial fibrillation: The LIFE study
Journal of the American College of Cardiology·2003· 4 cited
Prognostic significance of left ventricular hypertrophy during treatment of hypertension: The LIFE study
Journal of the American College of Cardiology·2003· 2 cited
page 1 of 2Next →

Frequent Co-authors

Kristian Wachtell(32), Hans Ibsen(22), Michael Hecht Olsen(19), Eva Gerdts(17), Richard B. Devereux(16), Vasilios Papademetriou(14), Jonathan N. Bella(14), Markku S. Nieminen(11), Richard B. Devereux(10), Björn Dahlöf(9), H Dige‐Petersen(9), Kurt Boman(8), Per Hildebrandt(8), Vittorio Palmieri(7), Christian Tuxen(7), Lia E. Bang(7), Björn Dahlöf(5), Sverre E. Kjeldsen(5), Eigil Fossum(5), Christian Hall(5)